| __timestamp | Amphastar Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 72429000 |
| Thursday, January 1, 2015 | 46974000 | 78634000 |
| Friday, January 1, 2016 | 47298000 | 75374000 |
| Sunday, January 1, 2017 | 50918000 | 92157000 |
| Monday, January 1, 2018 | 58044000 | 93326000 |
| Tuesday, January 1, 2019 | 63109000 | 103132000 |
| Wednesday, January 1, 2020 | 65157000 | 110171000 |
| Friday, January 1, 2021 | 68920000 | 218817000 |
| Saturday, January 1, 2022 | 66592000 | 233827000 |
| Sunday, January 1, 2023 | 80393000 | 267194000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. Over the past decade, Lantheus Holdings, Inc. and Amphastar Pharmaceuticals, Inc. have showcased contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Lantheus Holdings saw a staggering 270% increase in SG&A expenses, peaking in 2023. This growth reflects their aggressive expansion and strategic investments. In contrast, Amphastar Pharmaceuticals experienced a more modest 99% rise, indicating a steady yet cautious approach to operational spending.
These insights provide a window into the strategic priorities of these companies, offering investors a glimpse into their operational philosophies.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for MorphoSys AG and Amphastar Pharmaceuticals, Inc.
Comparing SG&A Expenses: HUTCHMED (China) Limited vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights